Research from the Stanford Human Immune Monitoring Center has identified a distinct immunological signature in long COVID patients characterized by low cortisol levels, persistent viral antigen in gut tissue, and altered T-cell responses that together produce a biological state quite different from healthy recovered individuals. The findings provide the most comprehensive mechanistic explanation to date for the debilitating fatigue, cognitive impairment, and autonomic dysfunction that characterize the condition.
The identified mechanisms are guiding clinical trial design, with studies now testing antiviral agents targeting persistent viral reservoir, cortisol replacement therapy, and immune modulating drugs in populations selected for the biological signatures identified in the Stanford research. Patient advocates who have pushed for years to have long COVID recognized as a biological rather than psychological condition view the mechanistic findings as validation and hope for treatments that have been too long in coming.
